Background: Testing the association between a diallelic marker and a censored time-to-event trait is a specific problem in population-based association studies. For a certain gene, the mode ... tests (or minimum p…
variety of statistical methods are available to investigators for analysis of time-to-event data, often referred to as survival analysis. Kaplan-Meier estimation and Cox proportional hazards regression ... constant…
extended to apply for different types of data, including independent data, time-to-event data and longitudinal data. Consequently, we present a brief review of QR and its related models
want to discover the genes whose expression levels are associated with a time-to-event endpoint, such as progression free survival or overall survival, through microarray studies. In this case ... review a FDR-control…
etiological association. One particular retrospective sampling is that disease outcomes of the time-to-event type are collected subject to right truncation, along with other covariates of interest. For regression…
data scientists. Notable areas of advancement in biostatistics include the analysis of complex time-to-event data and addressing issues related to missing data. These challenges have become particularly prominent
novelty. Additionally, we found little difference in price among drugs approved based on time-to-event end points and drugs approved on the basis of RR. Our results suggest that
differences, drug-induced effects and causal relationships can be difficult to interpret. Parametric time-to-event models and population pharmacokinetic– pharmacodynamic modeling are increasingly being used to address…
were compared to SAB isolates from the general population by comparing spa types. Time-to-event data were analyzed using Cox regression models and spa type differences using Chi-squared
extracted data and performed meta-analyses of Hazard Ratios (HR) for time-to-event variables and Risk Ratios (RR) for dichotomous outcomes, with 95% Confidence Intervals (CI). We used ROBINS
varying follow-up periods among the included studies were resolved by analysis of time-to-event outcomes. Results: Eighteen comparative studies enrolling 6133 patients were eligible. No difference was found
extracted data and performed meta-analyses of Hazard Ratios (HR) for time-to-event variables and Risk Ratios (RR) for dichotomous outcomes, with 95% Confidence Intervals (CI). We used ROBINS
multivariate level, greater denial score was more prevalent in singles, those with time-to-event of ≤ 1 year, those sustained arrhythmias, those who perceived good health, and those received
risk was used. Significance testing by chi-square, Fisher’s exact test and time-to-event curves were generated by the Kaplan-Meier method and compared using the log-rank
risk was used. Significance testing by chi-square, Fisher’s exact test and time-to-event curves were generated by the Kaplan-Meier method and compared using the log-rank
duration of MCS support, PCI-outcomes and survival to 30-days. A time-to-event analysis was performed using patient survival as the primary outcome measure. Results: Twenty-three patients
When analyzing time-to-event data in a non-parametric setting without considering covariates, the Kaplan-Meier estimator is widely used to estimate the survival function. When considering covariates
study were to estimate the incidence of DRCs among cART recipients, assess the time-to-event in the presence of censored cases and identify cART regimens most associated with DRCs
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.